1. Home
  2. RFIL vs SMTI Comparison

RFIL vs SMTI Comparison

Compare RFIL & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RF Industries Ltd.

RFIL

RF Industries Ltd.

HOLD

Current Price

$18.57

Market Cap

191.3M

Sector

Technology

ML Signal

HOLD

Logo Sanara MedTech Inc.

SMTI

Sanara MedTech Inc.

N/A

Current Price

$21.50

Market Cap

208.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RFIL
SMTI
Founded
1979
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
191.3M
208.2M
IPO Year
1996
2008

Fundamental Metrics

Financial Performance
Metric
RFIL
SMTI
Price
$18.57
$21.50
Analyst Decision
Hold
Strong Buy
Analyst Count
1
2
Target Price
$11.25
$34.00
AVG Volume (30 Days)
229.1K
36.6K
Earning Date
06-15-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
101.59
N/A
EPS
N/A
0.05
Revenue
$55,325,000.00
$15,586,976.00
Revenue This Year
$9.65
$17.31
Revenue Next Year
$6.40
$12.48
P/E Ratio
$1,203.00
$459.80
Revenue Growth
10.22
32.47
52 Week Low
$4.08
$16.05
52 Week High
$19.77
$35.70

Technical Indicators

Market Signals
Indicator
RFIL
SMTI
Relative Strength Index (RSI) 58.26 50.84
Support Level $6.31 $20.52
Resistance Level $19.39 $24.17
Average True Range (ATR) 1.45 1.14
MACD -0.25 -0.15
Stochastic Oscillator 72.91 28.16

Price Performance

Historical Comparison
RFIL
SMTI

About RFIL RF Industries Ltd.

RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company has one operating segment. The company operates in Canada, Germany, China, the USA, and the United Kingdom, and Others.

About SMTI Sanara MedTech Inc.

Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.

Share on Social Networks: